F16.229

Clinical Causes: Repeated use of hallucinogenic substances such as LSD, psilocybin, or peyote. Psychological factors including underlying mental health conditions, stress, or trauma. Environmental cues or social settings that promote substance use. Genetic predisposition to substance dependence. History of substance use disorder or other addictive behaviors.

Key Symptoms: Persistent craving for hallucinogens. Tolerance, requiring larger doses to achieve the desired effect. Withdrawal symptoms upon reducing or stopping use, such as anxiety or agitation. Altered sensory perception, including visual or auditory hallucinations. Impaired judgment and difficulty functioning in daily activities. Preoccupation with obtaining and using hallucinogens. Repeated unsuccessful efforts to cut down or control use. Mood swings, confusion, or paranoia during intoxication.

Diagnosis Path: Diagnosis is based on clinical assessment of recent use of hallucinogenic substances, signs of dependence, and intoxication. Healthcare providers may utilize standardized questionnaires and conduct interview-based evaluations to establish patterns of use and dependence. Laboratory tests are generally not definitive but can support the clinical findings by identifying recent substance use. The diagnosis requires evidence of dependence combined with recent intoxication episodes.

Treatment Protocols: Treatment approaches include a combination of behavioral therapies, counseling, and support groups aimed at managing dependence and preventing relapse. Medications are not typically used to treat hallucinogen dependence directly, but managing withdrawal symptoms or associated mental health issues may involve pharmacological interventions. Long-term recovery usually requires ongoing psychological support, lifestyle changes, and addressing underlying psychological factors that contribute to drug use.